Gene One Life Science Inc (011000) Stock Price & News

All values in KRW	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	5,08 mjd	2,65 mjd	2,58 mjd	2,06 mjd
Cost of goods sold	8,86 mjd	9,09 mjd	2,56 mjd	8,78 mjd
Cost of revenue	8,86 mjd	9,09 mjd	2,56 mjd	8,78 mjd
Research and development expenses	659,29 m	289,06 m	5,93 m	315,30 m
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5,19 mjd	4,30 mjd	2,03 mjd	2,45 mjd
Operating expense	7,88 mjd	6,69 mjd	2,36 mjd	8,14 mjd
Total operating expenses	16,74 mjd	15,78 mjd	4,92 mjd	16,92 mjd
Operating income	-11,66 mjd	-13,12 mjd	-2,34 mjd	-14,86 mjd
Other non operating income	743,26 m	8,19 m	-6,40 m	-2,96 mjd
EBT including unusual items	-11,48 mjd	-16,24 mjd	-2,38 mjd	-18,95 mjd
EBT excluding unusual items	-11,52 mjd	-16,24 mjd	-2,38 mjd	-18,89 mjd
Income tax expense	-7,89 m	-100,93 m	-	-
Effective tax rate	0,07%	0,62%	-	-
Other operating expenses	178,87 m	130,87 m	16,68 m	18,10 m
Net income	-11,47 mjd	-16,14 mjd	-2,38 mjd	-18,95 mjd
Net profit margin	-225,92%	-608,48%	-92,29%	-921,57%
Earnings per share	-	-	-	-
Interest and investment income	33,38 m	87,93 m	48,23 m	270,06 m
Interest expense	-647,78 m	-3,20 mjd	-211,98 m	-1,29 mjd
Net interest expenses	-614,40 m	-3,12 mjd	-163,75 m	-1,02 mjd
Depreciation and amortization charges	1,76 mjd	1,81 mjd	295,04 m	2,99 mjd
EBITDA	-7,22 mjd	-8,56 mjd	-2,04 mjd	-7,05 mjd
Gain or loss from assets sale	-39,28 m	-4,55 m	-	54,01 m

Finance